Latest Whitepapers

The sensitivity and specificity of mass spectrometry (MS) has made it an indispensable tool for biopharmaceutical analysis, ensuring the safety and efficacy of biologics.

This article presents current techniques in oligonucleotide production and characterization, highlighting recent advancements that enhance the efficiency of these methods

This article explores how scientists are tackling the challenges and intensifying efforts to develop mRNA therapeutics for different diseases.

Chimeric antigen receptor (CAR) therapies involve the use of engineered receptors capable of redirecting immune cells to recognize and destroy cancer cells expressing a specific antigen. Currently, CAR T cells dominate the field of CAR therapy.

This whitepaper explores the cutting-edge cloud-based antibody selection tools, that provide confident and timely antibody selection. It also highlights the latest analysis software for independent, intricate analyses and optimal antibody selection.

This whitepaper highlights the latest bioprocessing film technologies to help you meet your upstream and downstream needs.

This whitepaper explores how to track HCPs of concern through purification steps, develop robust removal strategies and increase the HCP population coverage achieved.

These whitepapers highlight how optimized CRISPR protocols and site-specific knock-in technology can be used to engineer simple or complex genetic modifications in allogenic iPSCs.

The diagnostic industry is a crucial pillar of modern healthcare. It equips clinicians with vital tools and provides consumers with a range of at-home testing solutions. This whitepaper features industry experts in discussing the key challenges in diagnostics and how to tackle them.

This whitepaper highlights how the latest software can help researchers overcome the uncertainties in drug discovery and enable efficient compound design, synthesis and progression tracking.